These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 24023620)

  • 1. New preclinical antimalarial drugs potently inhibit hepatitis C virus genotype 1b RNA replication.
    Ueda Y; Takeda M; Mori K; Dansako H; Wakita T; Kim HS; Sato A; Wataya Y; Ikeda M; Kato N
    PLoS One; 2013; 8(8):e72519. PubMed ID: 24023620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-HCV activity of the Chinese medicinal fungus Cordyceps militaris.
    Ueda Y; Mori K; Satoh S; Dansako H; Ikeda M; Kato N
    Biochem Biophys Res Commun; 2014 May; 447(2):341-5. PubMed ID: 24726408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of action of ribavirin in a novel hepatitis C virus replication cell system.
    Mori K; Ikeda M; Ariumi Y; Dansako H; Wakita T; Kato N
    Virus Res; 2011 Apr; 157(1):61-70. PubMed ID: 21320556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plural assay systems derived from different cell lines and hepatitis C virus strains are required for the objective evaluation of anti-hepatitis C virus reagents.
    Ueda Y; Mori K; Ariumi Y; Ikeda M; Kato N
    Biochem Biophys Res Commun; 2011 Jun; 409(4):663-8. PubMed ID: 21620801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of ribavirin on HCV replicon RNA decline during treatment with interferon-α and the protease inhibitors boceprevir or telaprevir.
    Hofmann WP; Chung TL; Osbahr C; Susser S; Karey U; Mihm U; Welsch C; Lötsch J; Sarrazin C; Zeuzem S; Herrmann E
    Antivir Ther; 2011; 16(5):695-704. PubMed ID: 21817191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of anti-hepatitis C virus effects of interferon and ribavirin by a sensitive replicon system.
    Kato T; Date T; Miyamoto M; Sugiyama M; Tanaka Y; Orito E; Ohno T; Sugihara K; Hasegawa I; Fujiwara K; Ito K; Ozasa A; Mizokami M; Wakita T
    J Clin Microbiol; 2005 Nov; 43(11):5679-84. PubMed ID: 16272504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mizoribine inhibits hepatitis C virus RNA replication: effect of combination with interferon-alpha.
    Naka K; Ikeda M; Abe K; Dansako H; Kato N
    Biochem Biophys Res Commun; 2005 May; 330(3):871-9. PubMed ID: 15809077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenosine kinase is a key determinant for the anti-HCV activity of ribavirin.
    Mori K; Hiraoka O; Ikeda M; Ariumi Y; Hiramoto A; Wataya Y; Kato N
    Hepatology; 2013 Oct; 58(4):1236-44. PubMed ID: 23532970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Life style-related diseases of the digestive system: cell culture system for the screening of anti-hepatitis C virus (HCV) reagents: suppression of HCV replication by statins and synergistic action with interferon.
    Ikeda M; Kato N
    J Pharmacol Sci; 2007 Oct; 105(2):145-50. PubMed ID: 17928739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of subgenomic hepatitis C virus RNA replication in HeLa cells.
    Kanda T; Yokosuka O; Mikata R; Zhang KY; Tanaka M; Tada M; Fukai K; Imazeki F; Saisho H
    Hepatogastroenterology; 2007; 54(73):32-5. PubMed ID: 17419226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-interferon-α neutralizing antibody induced telaprevir resistance under the interferon-α plus telaprevir treatment in vitro.
    Kuga C; Enomoto H; Aizawa N; Takashima T; Ikeda N; Ishii A; Sakai Y; Iwata Y; Tanaka H; Saito M; Iijma H; Nishiguchi S
    Biochem Biophys Res Commun; 2014 Nov; 454(3):453-8. PubMed ID: 25450683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effects of Pycnogenol® on hepatitis C virus replication.
    Ezzikouri S; Nishimura T; Kohara M; Benjelloun S; Kino Y; Inoue K; Matsumori A; Tsukiyama-Kohara K
    Antiviral Res; 2015 Jan; 113():93-102. PubMed ID: 25446333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-ulcer agent teprenone inhibits hepatitis C virus replication: potential treatment for hepatitis C.
    Ikeda M; Kawai Y; Mori K; Yano M; Abe K; Nishimura G; Dansako H; Ariumi Y; Wakita T; Yamamoto K; Kato N
    Liver Int; 2011 Jul; 31(6):871-80. PubMed ID: 21645219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic inhibition of intracellular hepatitis C virus replication by combination of ribavirin and interferon- alpha.
    Tanabe Y; Sakamoto N; Enomoto N; Kurosaki M; Ueda E; Maekawa S; Yamashiro T; Nakagawa M; Chen CH; Kanazawa N; Kakinuma S; Watanabe M
    J Infect Dis; 2004 Apr; 189(7):1129-39. PubMed ID: 15031779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery and characterization of substituted diphenyl heterocyclic compounds as potent and selective inhibitors of hepatitis C virus replication.
    Huang P; Goff DA; Huang Q; Martinez A; Xu X; Crowder S; Issakani SD; Anderson E; Sheng N; Achacoso P; Yen A; Kinsella T; Darwish IS; Kolluri R; Hong H; Qu K; Stauffer E; Goldstein E; Singh R; Payan DG; Lu HH
    Antimicrob Agents Chemother; 2008 Apr; 52(4):1419-29. PubMed ID: 18227176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of preclinical antimalarial drugs, which can overcome direct-acting antivirals-resistant hepatitis C viruses, using the viral reporter assay systems.
    Ueda Y; Dansako H; Satoh S; Kim HS; Wataya Y; Doi H; Ikeda M; Kato N
    Virus Res; 2017 May; 235():37-48. PubMed ID: 28322919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment of hepatitis C virus RNA-replicating cell lines possessing ribavirin-resistant phenotype.
    Satoh S; Mori K; Ueda Y; Sejima H; Dansako H; Ikeda M; Kato N
    PLoS One; 2015; 10(2):e0118313. PubMed ID: 25699517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of the replication of a hepatitis C virus-like RNA template by interferon and 3'-deoxycytidine.
    King RW; Zecher M; Jefferies MW
    Antivir Chem Chemother; 2002 Nov; 13(6):363-70. PubMed ID: 12718408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis C virus replication is inhibited by 22beta-methoxyolean-12-ene-3beta, 24(4beta)-diol (ME3738) through enhancing interferon-beta.
    Hiasa Y; Kuzuhara H; Tokumoto Y; Konishi I; Yamashita N; Matsuura B; Michitaka K; Chung RT; Onji M
    Hepatology; 2008 Jul; 48(1):59-69. PubMed ID: 18459156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and inhibitory activity on hepatitis C virus RNA replication of 4-(1,1,1,3,3,3-hexafluoro-2-hydroxy-2-propyl)aniline analogs.
    Matsuno K; Ueda Y; Fukuda M; Onoda K; Waki M; Ikeda M; Kato N; Miyachi H
    Bioorg Med Chem Lett; 2014 Sep; 24(17):4276-80. PubMed ID: 25086684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.